Abo Bibliothek: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 1045-4403

ISSN Online: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Malignant Melanoma: Skin Cancer−Diagnosis, Prevention, and Treatment

Volumen 30, Ausgabe 4, 2020, pp. 291-297
DOI: 10.1615/CritRevEukaryotGeneExpr.2020028454
Get accessGet access

ABSTRAKT

Melanoma is a skin cancer caused by a malignancy of melanocytes. Incidence of melanoma is rapidly increasing worldwide, which results in public health problems. Primary extracutaneous melanomas can be ocular, gastrointestinal, mucosal, leptomeningeal, genitourinary, and lymphatic. The relationship between exposure to ultraviolet (UV) light and development of melanoma is intensively acute and complex, and intermittent sun exposure greatly increases the risk of melanoma. It is the fifth most common type of cancer in men number and the sixth most common in women. The diagnosis of melanoma is made through clinical assessment of the pigmented by health care professionals. Architectural features of malignant melanoma including asymmetry, confluence of growth, marked cellularity, and poor circumscription. The cytological feature of malignant melanoma include an irregular and thick nuclear membrane and prominent nucleoli. The preventive measures include reducing exposure to UV light and the sun. The early detection of skin cancer greatly reduces both short- and long-term morbidity and mortality. The treatment and follow-up with the doctor for melanoma patients may differ because of the stage of the tumor and the primary lesion. The typical therapy for malignant melanoma is surgical excision, immunotherapy such as interleukin 2 (IL-2), gene therapy, and biochemotherapy.

REFERENZEN
  1. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu C-G, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297(17):1901-8.

  2. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93(9):678-83.

  3. Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):2766-92.

  4. Elwood JM, Gallagher RP. Site distribution of malignant melanoma. Canadian Med Asso J. 1983;128(12):1400.

  5. Rigel DS. Malignant melanoma. CA Cancer J Clin. 2000;50(4):215-36.

  6. Robinson MR, Chan C-C, Yang JC, Rubin BI, Gracia GJ, Sen HN, Csaky KG, Rosenberg SA. Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with meta-static melanoma: A new cause of uveitis. J Immunother. 2004;27(6):478-9.

  7. Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D. Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria. JAMA. 2004;292(22):2771-6.

  8. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364-80.

  9. Gonzalez A, West AJ, Pitha JV, Taira JW. Small-diameter invasive melanomas: Clinical and pathologic characteristics. J Cutan Pathol. 1996;23(2):126-32.

  10. Kamino H, Kiryu H, Ratech H. Small malignant melanomas: Clinicopathologic correlation and DNA ploidy analysis. J Am Acad Dermatol. 1990;22(6):1032-8.

  11. McNutt NS, Urmacher C, Hakimian J, Hoss DM, Lugo J. Nevoid malignant melanoma: Morphologic patterns and immunohistochemical reactivity. J Cutan Pathol. 1995;22(6):502-17.

  12. Balch CM. Cutaneous melanoma: Prognosis and treatment results worldwide. Semin Surg Oncol. 1992;8(6):400-14.

  13. Cascinelli N, Zurrida S, Galimberti V, Bartoli C, Bufalino R, Del Prato I, Mascheroni L, Testori A, Clemente C. Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol. 1994;20(12):817-22.

  14. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma. A summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664-78.

  15. Newell GR, Sider JG, Bergfelt L, Kripke ML. Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res. 1988;48(17):5036-41.

  16. Cox NH, Aitchison TC, Sirel JM, MacKie RM. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer. 1996;73(7):940-4.

  17. Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81(24):1893-904.

  18. Crowson AN, Magro CM, Mihm MC Jr. The melanocytic proliferations: A comprehensive textbook of pigmented lesions. Hoboken, NJ: John Wiley & Sons; 2001.

  19. Barnhill RL, Piepkorn M, Busam KJ. Pathology of melanocytic nevi and malignant melanoma. New York: Springer Science & Business Media; 2014.

  20. Kaskel P, Sander S, Kron M, Kind P, Peter RU, Krahn G. Outdoor activities in childhood: A protective factor for cutaneous melanoma? Results of a case-control study in 271 matched pairs. Br J Dermatol. 2001;145(4):602-9.

  21. Grob JJ, Guglielmina C, Gouvernet J, Zarour H, Noe C, Bonerandi JJ. Study of sunbathing habits in children and adolescents: Application to the prevention of melanoma. Dermatology. 1993;186(2):94-8.

  22. Montague M, Borland R, Sinclair C. Slip! Slop! Slap! and Sun Smart, 1980-2000: Skin cancer control and 20 years of population-based campaigning. Health Educ Behav. 2001;28(3):290-305.

  23. Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol. 2006;54(1):105-14.

  24. Marks R. An overview of skin cancers. Incidence and causation. Cancer. 1995;75(2 Suppl):607-12.

  25. Qadir MI. Skin cancer: Etiology and management. Pak J Pharm Sci. 2016;29(3):999-1003.

  26. Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin. 2000;50(4):215-36.

  27. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37(2):236-45.

  28. Qadir MI. Medicinal and cosmetological importance of Aloe vera. Int J Nat Ther. 2009;2:21-6.

REFERENZIERT VON
  1. Li Ling, Ji Yanting, Zhang Lili, Cai Hengji, Ji Zhoujing, Gu Lixiong, Yang Shengju, Wogonin inhibits the growth of HT144 melanoma via regulating hedgehog signaling-mediated inflammation and glycolysis, International Immunopharmacology, 101, 2021. Crossref

  2. Chen Mi, Winston Dagogo Dorothy, Wang Min, Niu Wen, Cheng Wei, Guo Yi, Wang Yidan, Luo Meng, Xie Chenxi, Leng Tongtong, Qu Xiaoyan, Lei Bo, Hierarchically multifunctional bioactive nanoglass for integrated tumor/infection therapy and impaired wound repair, Materials Today, 53, 2022. Crossref

  3. Hawash Mohammed, Jaradat Nidal, Eid Ahmad M., Abubaker Ahmad, Mufleh Ola, Al-Hroub Qusay, Sobuh Shorooq, Synthesis of novel isoxazole–carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability, BMC Chemistry, 16, 1, 2022. Crossref

  4. Qadir M.I., Meet Our Editorial Board Member, Recent Patents on Biotechnology, 15, 1, 2021. Crossref

  5. Waqar Sara, George Sheeba, Jean-Baptiste Wilford, Yusuf Ali Amina, Inyang Bithaiah, Koshy Feeba Sam, George Kitty, Poudel Prakar, Chalasani Roopa, Goonathilake Mastiyage R, Mohammed Lubna, Recognizing Histopathological Simulators of Melanoma to Avoid Misdiagnosis, Cureus, 2022. Crossref

  6. Zhu Sirong, Sun Chao, Zhang Longjiang, Du Xiaoan, Tan Xiaodong, Peng Shuzhen, Incidence Trends and Survival Prediction of Malignant Skin Cancer: A SEER-Based Study, International Journal of General Medicine, Volume 15, 2022. Crossref

  7. Zhang Fangyingnan, Waheed Saquib, Armato Ubaldo, Wu Jun, Zhang Chao, Li Zhibin, eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma, Frontiers in Oncology, 12, 2022. Crossref

  8. Gong Zhenhua, Zhang Yi, Jiang Yasu, Chen Peng, Ji Jianfeng, Yang Dong-Hua, LncRNA NEAT1 Targets miR-342-3p/CUL4B to Inhibit the Proliferation of Cutaneous Squamous Cell Carcinoma Cells, Journal of Oncology, 2022, 2022. Crossref

  9. Sulaiman Akebaier, Lv Jin, Fan Junwei, Abuliezi Reyila, Zhang Qian, Wan Xuefeng, Wang Fu, Influencing Mechanism of Nod-Like Receptor Protein 3 Inflammasome Activation in A375 Cell Activity in Human Cutaneous Malignant Melanoma, Journal of Immunology Research, 2022, 2022. Crossref

  10. Rachinger Nicole, Mittag Nora, Böhme-Schäfer Ines, Xiang Wei, Kuphal Silke, Bosserhoff Anja K., Alpha-Synuclein and Its Role in Melanocytes, Cells, 11, 13, 2022. Crossref

  11. Xia Yun, Guan Jing, Lu Xu, Liu Yifan, Luan Wenkang, Novel lncRNA SNHG16 Promotes the Growth and Metastasis of Malignant Melanoma by Regulating miR-205-5p/PAK2 Axis, Clinical, Cosmetic and Investigational Dermatology, Volume 15, 2022. Crossref

  12. Jahn Anna Sophie, Navarini Alexander Andreas, Cerminara Sara Elisa, Kostner Lisa, Huber Stephanie Marie, Kunz Michael, Maul Julia-Tatjana, Dummer Reinhard, Sommer Seraina, Neuner Anja Dominique, Levesque Mitchell Paul, Cheng Phil Fang, Maul Lara Valeska, Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients’ Perception, Cancers, 14, 15, 2022. Crossref

  13. Xu Huangru, Li Ping, Wang Xiaoyang, Zhuang Hongqin, Hua Zi-Chun, Emerging roles of hnRNP A2B1 in cancer and inflammation, International Journal of Biological Macromolecules, 221, 2022. Crossref

  14. Zeng Ni, Xia Qingyue, Li Yueyue, Ma Liwen, Cheng Yuxin, Chen Yihe, Lu Qian, Lu Zhiyu, Wu Di, Luo Dan, Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma, Current Pharmaceutical Design, 28, 28, 2022. Crossref

  15. Koizumi Koichi, Shintani Tomoaki, Hayashido Yasutaka, Hamada Atsuko, Higaki Mirai, Yoshioka Yukio, Sakamoto Akihiko, Yanamoto Souichi, Okamoto Tetsuji, VEGF-A promotes the motility of human melanoma cells through the VEGFR1–PI3K/Akt signaling pathway, In Vitro Cellular & Developmental Biology - Animal, 58, 8, 2022. Crossref

  16. Long Zhao-Bo, Li Feng, New Luminescent Zn(II)-Based Complex with Preventive and Inhibitory Effects on Skin Cancer, Science of Advanced Materials, 14, 5, 2022. Crossref

  17. Xu Jie, Shi Pengfei, Xia Fanwei, Zhao Xuan, Chen Junfan, Geng Rui, Cui Hongjuan, Yang Liqun, RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway, International Journal of Molecular Sciences, 23, 19, 2022. Crossref

  18. Fan Shuwen, Liu Xiao, Wu Yizhu, Li Ke, Zhao Xiaoyu, Lin Wei, Liu Jianjiang, Wu Xueliang, Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma, Evidence-Based Complementary and Alternative Medicine, 2022, 2022. Crossref

  19. Brănişteanu Daciana Elena, Cozmin Mihai, Porumb-Andrese Elena, Brănişteanu Daniel, Toader Mihaela Paula, Iosep Diana, Sinigur Diana, Brănişteanu Cătălina Ioana, Brănişteanu George, Porumb Vlad, Pînzariu Alin Constantin, Băilă Sorin Liviu, Nicolescu Alin Codruț, Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a Clinical Point of View, Medicina, 58, 11, 2022. Crossref

  20. Lu Jianxiu, Wang Wenjuan, Xu Ze, Zhang Peiying, Gu Jiake, Xu Zhilong, Xi Juqun, Fan Lei, CaCO3-assistant synthesis of pH/near-infrared light-responsive and injectable sodium alginate hydrogels for melanoma synergistic treatment, Journal of Colloid and Interface Science, 633, 2023. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain